| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |